🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2021-07-29
Trial ID
NCT04811716
Treatments Being Tested
The primary objective of the study is to assess the concentration-time prof...
Status
Completed
Location
Regeneron Research Site
Start Date
2021-08-04
Trial ID
NCT04940364
Treatments Being Tested
The primary objective of the study is to evaluate the long-term safety, tol...
Status
Terminated
Location
Regeneron Study Site
Start Date
2019-12-03
Trial ID
NCT04162470
Treatments Being Tested
The program is to provide access to an experimental drug called pozelimab a...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06003881
Treatments Being Tested
This study is researching a clinical treatment combination with two experim...
Status
Active Not Recruiting
Location
The Oncology Institute of Hope & Innovation
Start Date
2022-08-01
Trial ID
NCT05133531
Treatments Being Tested
The primary objective of the study is to demonstrate a reduction in intrava...
Status
Completed
Location
Regeneron Study Site
Start Date
2019-05-16
Trial ID
NCT03946748
Treatments Being Tested
This study is researching an experimental drug called pozelimab (called "st...
Status
Recruiting
Location
Colorado Retina Associates
Start Date
2026-01-19
Trial ID
NCT07230834
Treatments Being Tested
Provide compassionate use of pozelimab...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05232110
Treatments Being Tested
This program is designed to provide access to pozelimab and cemdisiran and ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06028594
Treatments Being Tested
The primary objective of the study is to compare the pharmacokinetic(PK) pr...
Status
Completed
Location
Regeneron Study Site
Start Date
2020-08-03
Trial ID
NCT04491838
Treatments Being Tested